|
1
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun H, Huang Z, Sheng W and Xu M: Emerging
roles of long non-coding RNAs in tumor metabolism. J Hematol Oncol.
11:1062018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Hum Molr Genet. 19:152–161. 2010.
View Article : Google Scholar
|
|
7
|
Ewan AG, Carolyn JB and Wan LL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
John RP and Arul MC: The emergence of
lncRNAs in cancer biology. Cancer Discov. 1:391–407. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough H, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by non-coding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gabory A, Jammes H and Dandolo L: The H19
locus: Role of an imprinted non-coding RNA in growth and
development. Bioessays. 32:473–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Panzitt K, Tschernatsch MM, Guelly C,
Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder
R, Trauner M and Zatloukal K: Characterization of HULC, a novel
gene with striking up-regulation in hepatocellular carcinoma, as
noncoding RNA. Gastroenterology. 132:330–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rasool M, Malik A, Zahid S, Basit Ashraf
MA, Qazi MH, Asif M, Zaheer A, Arshad M, Raza A and Jamal MS:
Non-coding RNAs in cancer diagnosis and therapy. Noncoding RNA Res.
1:69–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani I, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing identifies PCAT-1,
a novel lincRNA implicated in prostate cancer progression. Nat
Biotechnol. 29:742–749. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prensner JR, Wei C, Sumin H, Iyer MK, Cao
Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, et al:
The long non-coding RNA PCAT-1 promotes prostate cancer cell
proliferation through cMyc. Neoplasia. 16:900–908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi WH, Wu QQ, Li SQ, Yang TX, Liu ZH,
Tong YS, Tuo L, Wang S and Cao XF: Upregulation of the long
noncoding RNA PCAT-1 correlates with advanced clinical stage and
poor prognosis in esophageal squamous carcinoma. Tumour Biol.
36:2501–2507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiao L, Liu X, Tang Y, Zhao Z, Zhang J and
Liu H: Knockdown of long non-coding RNA prostate cancer-associated
ncRNA transcript 1 inhibits multidrug resistance and
c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and
HT-29 cells. Mol Cell Biochem. 441:99–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang J, Deng G, Liu T, Chen W and Zhou Y:
Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by
reducing p21 levels. Biochem Biophys Res Commun. 495:2622–2629.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang C, He W, Xu TY, Dai J, Xu L and Sun
F: Upregulation of lncRNA DGCR5 correlates with better prognosis
and inhibits bladder cancer progression via transcriptionally
facilitating P21 expression. J Cell Physiol. 234:6254–6262. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Waldman T, Kinzler KW and Vogelstein B:
p21 is necessary for the p53-mediated G1 arrest in human cancer
cells. Cancer Res. 55:5187–5190. 1995.PubMed/NCBI
|
|
23
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okuyemi OT, Piccirillo JF and Spitznagel
E: TNM staging compared with a new clinicopathological model in
predicting oral tongue squamous cell carcinoma survival. Head Neck.
36:1481–1489. 2014.PubMed/NCBI
|
|
25
|
Gao W, Chan YW and Wong TS: Long
non-coding RNA deregulation in tongue squamous cell carcinoma.
Biomed Res Int. 2014:4058602014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Varambally S, Dhanasekaran SM, Zhou M,
Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt
RG, Otte AP, et al: The polycomb group protein EZH2 is involved in
progression of prostate cancer. Nature. 419:624–629. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tedeschi A, Wutz G, Huet S, Jaritz M,
Wuensche A, Schirghuber E, Davidson IF, Tang W, Cisneros DA,
Bhaskara V, et al: Wapl is an essential regulator of chromatin
structure and chromosome segregation. Nature. 501:564–568. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Chen W, Fu X, Su X and Yang A:
CBX3 promotes tumor proliferation by regulating G1/S phase via p21
downregulation and associates with poor prognosis in tongue
squamous cell carcinoma. Gene. 654:49–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
